Two Sigma Securities’s Xtant Medical Holdings XTNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,000
Closed -$5.58K 2460
2026
Q1
$5.58K Sell
10,000
-67,350
-87% -$41.5K ﹤0.01% 1508
2025
Q4
$60.6K Buy
+77,350
New +$56.2K 0.01% 1045
2025
Q1
Sell
-23,126
Closed -$10.2K 2312
2024
Q4
$10.2K Sell
23,126
-976
-4% -$473 ﹤0.01% 1433
2024
Q3
$16.3K Buy
+24,102
New +$15.9K ﹤0.01% 2529
2023
Q3
Sell
-25,238
Closed -$23.5K 3565
2023
Q2
$23.5K Buy
25,238
+9,118
+57% +$6.08K ﹤0.01% 2485
2023
Q1
$10.3K Buy
+16,120
New +$11.8K ﹤0.01% 2451
2022
Q1
Sell
-22,958
Closed -$13K 2585
2021
Q4
$13K Buy
+22,958
New +$21.6K ﹤0.01% 1456

Other funds holding XTNT

Two Sigma Securities's XTNT Position: Q2 2026 in Review

Two Sigma Securities sold out of Xtant Medical Holdings (XTNT) in Q2 2026, closing a stake of 10,000 shares — an estimated $5.58K sold.

Two Sigma Securities first reported a position in XTNT in Q4 2021 and held it in 7 quarters. The position peaked at $60.6K in Q4 2025. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

  • Two Sigma Securities reported no remaining Xtant Medical Holdings position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 10,000 Xtant Medical Holdings shares in Q2 2026, an estimated $5.58K.
  • Two Sigma Securities first reported a position in Xtant Medical Holdings in Q4 2021 and held it in 7 quarters.
  • Two Sigma Securities's Xtant Medical Holdings position peaked at $60.6K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.